Beijing Strong Biotechnologies,Inc.

SZSE:300406 Stock Report

Market Cap: CN¥8.2b

Beijing Strong BiotechnologiesInc Future Growth

Future criteria checks 3/6

Beijing Strong BiotechnologiesInc is forecast to grow earnings and revenue by 23.2% and 19.8% per annum respectively. EPS is expected to grow by 23% per annum. Return on equity is forecast to be 15.6% in 3 years.

Key information

23.2%

Earnings growth rate

23.0%

EPS growth rate

Biotechs earnings growth43.4%
Revenue growth rate19.8%
Future return on equity15.6%
Analyst coverage

Low

Last updated30 Oct 2024

Recent future growth updates

No updates

Recent updates

Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?

Jul 25
Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?

Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price

Jul 03
Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price

An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued

Jun 14
An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued

Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?

Mar 21
Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?

Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified

Mar 03
Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified

Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)

Feb 27
Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)

Earnings and Revenue Growth Forecasts

SZSE:300406 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,826912N/A7822
12/31/20252,437763N/A5552
12/31/20242,056619N/A3882
9/30/20241,745526524621N/A
6/30/20241,747533521640N/A
3/31/20241,762533436589N/A
12/31/20231,742524437585N/A
9/30/20231,622491375506N/A
6/30/20231,615468297420N/A
3/31/20231,512402299397N/A
12/31/20221,511389300396N/A
9/30/20221,504364313426N/A
6/30/20221,504347304402N/A
3/31/20221,598392280372N/A
1/1/20221,599406276341N/A
9/30/20211,539335244275N/A
6/30/20211,391299193218N/A
3/31/20211,109212112132N/A
12/31/2020848112106123N/A
9/30/202079720280119N/A
6/30/202075223467115N/A
3/31/2020781284106154N/A
12/31/2019841332127189N/A
9/30/2019813324134194N/A
6/30/2019787318171247N/A
3/31/2019783303162239N/A
12/31/2018774301183256N/A
9/30/2018755285185252N/A
6/30/2018748279N/A210N/A
3/31/2018718280N/A209N/A
12/31/2017694273N/A208N/A
9/30/2017657266N/A205N/A
6/30/2017660259N/A251N/A
3/31/2017658259N/A254N/A
12/31/2016667272N/A243N/A
9/30/2016646266N/A228N/A
6/30/2016595259N/A145N/A
3/31/2016590255N/A144N/A
12/31/2015566245N/A143N/A
9/30/2015548222N/A130N/A
6/30/2015543218N/A165N/A
3/31/2015524218N/A146N/A
12/31/2014508211N/A157N/A
9/30/2014480205N/A170N/A
12/31/2013445181N/A147N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300406's forecast earnings growth (23.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 300406's earnings (23.2% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 300406's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300406's revenue (19.8% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 300406's revenue (19.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300406's Return on Equity is forecast to be low in 3 years time (15.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y